Web Results

Mecasermin - Wikipedia


Mecasermin (INN) (trade name Increlex) is recombinant human insulin-like growth factor 1 (IGF-I), which is used for the long-term treatment of growth failure in ...

Mecasermin: Indications, Side Effects, Warnings - Drugs.com


Easy to read patient leaflet for mecasermin. Includes indications, proper use, special instructions, precautions, and possible side effects.

DailyMed - INCRELEX- mecasermin injection, solution


1.1 Severe Primary IGF-1 Deficiency (Primary IGFD) INCRELEX® (mecasermin [ rDNA origin] injection) is indicated for the treatment of: growth failure in .

Mecasermin (recombinant human insulin-like growth factor I). - NCBI


Adv Ther. 2009 Jan;26(1):40-54. doi: 10.1007/s12325-008-0136-5. Epub 2009 Jan 28. Mecasermin (recombinant human insulin-like growth factor I).

Insulin-Like Growth Factor-1 (IGF-1) Analogues: Mecasermin ... - Aetna


Number: 0711. Policy. Aetna considers mecasermin (Increlex) and mecasermin rinfabate (Iplex)* medically necessary for the treatment of growth failure in ...

Increlex (mecasermin) dosing, indications, interactions, adverse ...


Medscape - Indication-specific dosing for Increlex (mecasermin), frequency- based adverse effects, comprehensive interactions, contraindications, pregnancy  ...

INCRELEX, INN: mecasermin - European Medicines Agency


INCRELEX (mecasermin) is recombinant human insulin-like growth factor-1 ... Mecasermin was granted orphan status in the EU for “Treatment of growth ...

Increlex (Mecasermin) - Anabolic.org


Jul 29, 2016 ... Increlex mecasermin IGF-1 drug profile. Authoritative info on history, side effects, and effective dosages or cycles for muscle building and fat ...

Increlex (mecasermin) Drug Side Effects, Interactions, and ...


Drug information on Increlex (mecasermin), includes drug pictures, side effects, drug interactions, directions for use, symptoms of overdose, and what to avoid.

Increlex, INN-mecasermin - European Medicines Agency - Europa


The dose of mecasermin should never be increased to make up for one or more omitted doses. Injection sites should be rotated to a different site with each ...

More Info



Manufacturer's information about recombinant human insulin-like growth factor-1, marketed under the brand name Increlex (generic name mecasermin).

Increlex (mecasermin) - CenterWatch


Increlex (mecasermin): For the treatment of growth failure due to Primary IGFD. New approved drug details including side effects, uses and general information.

Mecasermin - DrugBank


May 16, 2007 ... Description, Mecasermin contains recombinant-DNA-engineered human insulin- like growth factor-1 (rhIGF-1). IGF-1 consists of 70 amino acids ...